ImmunityBio, Inc. IBRX

We have all seen that press release but it's not on TV so no TV no big price movement

I agree nothing or very little will happen with this latest news and the AUA talk. We know about it but the world doesn't.... no MSM coverage..... without MSM coverage it's tough to move the share price a lot.

Papillary FDA approval would help but once again who new will learn about it. The MSM has a lid on ImmunityBio and Merck tells them what to do. Merck spends a few billion a year on TV ads.

If we only could get a little MSM coverage like from CNBC FoxB they are as corrupt as the FDA greedy slaves to ad $$$$

You can't hold FDA approvals they are released to the company and media at the same time. Dr PSS needs to keep his mouth shut. Look at all the POS vulture law firms.

BCG shortage was because of how it has been made and hello Merck had the monopoly. Big Pharma ?

I am convinced Dr PPS and his fight with the BIG PHARMA CORRUPTED FDA and his friendship with RFK Jr. and Trump got Mackary and Prasad fired.

My bet, Anktiva gets approval for all cancer types like Keytruda got plus approval to treat Lymphopenia for low ALC and soon multiple infectious diseases too.

Hang on triple digits in 1-2 years and over $300 a share in 5 years.

We get no MSM coverage so not much moves IBRX

What will is sales approvals and show a profit some day

Sam ImmunityBio isn't for sale Dr PSS is working on his life long dream and mission and won't give up control to a POS BP company

It always feels better when a stock you own goes up some every day. No stock goes up every day. Most stocks go up some every year as long as their business is relevant and growing.

ImmunityBio is very relevant, curing treating cancer saving and extend life plus the potential to treat infections such as sepsis, AIDS and other chronic infections.

So with the relevance and huge potential for growth guess what. The stock price will have a parabolic rise over the next 1-5 years.

570,000 shares is what I hold for the ? ride

We didn't get rejected by the FDA they wanted to know BCG supply was adequate because Merck "couldn't" supply enough so Dr P went to India and now Japan too.

Maybe the FDA has said soon you will have papillary approval and many additional uses coming soon so you need to lock up the BCG supply to meet expand use for Anktiva...... just maybe that is what's happening.

FDA approvals require the ability to manufacture and meet demands also.